T-Cell Acute Lymphocytic Leukemia 2 (TAL2) (N-Term) Peptide
-
- Target See all TAL2 products
- TAL2 (T-Cell Acute Lymphocytic Leukemia 2 (TAL2))
- Protein Region
- N-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-TAL2 antibody (Catalog #: ARP38618_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- TAL2 (T-Cell Acute Lymphocytic Leukemia 2 (TAL2))
- Synonyms
- Tail2 Peptide, zgc:111884 Peptide, bHLHa19 Peptide, TAL bHLH transcription factor 2 Peptide, T-cell acute lymphocytic leukemia 2 Peptide, T-cell acute lymphocytic leukemia protein 2-like Peptide, T cell acute lymphocytic leukemia 2 Peptide, Tal2 Peptide, tal2 Peptide, TAL2 Peptide, LOC100229881 Peptide
- Background
-
TAL2 is a helix-loop-helix protein. Translocations between this gene on chromosome 9 and the T-cell receptor beta-chain locus on chromosome 7 have been associated with activation of the T-cell acute lymphocytic leukemia 2 gene and T-cell acute lymphoblastic leukemia.
Alias Symbols: -
Protein Interaction Partner: LMO1,LMO2,MAPK3,TCF3,LMO1,LMO2,TCF4
Protein Size: 108 - Molecular Weight
- 12 kDa
- Gene ID
- 6887
- NCBI Accession
- NM_005421, NP_005412
- UniProt
- Q16559
-